12:00 AM
Aug 19, 2013
 |  BC Week In Review  |  Company News  |  Deals

Bever Pharmaceutical Pte. Ltd., Pharmstandard deal

Pharmstandard said it has agreed to acquire Bever for $590 million comprised of $542 million in global depositary receipts (GDRs) and $48 million in cash. The acquisition...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >